Home > National Drug Code (NDC) > Gliocladium

Gliocladium - 49288-0217-4 - (Gliocladium)

Alphabetical Index


Drug Information of Gliocladium

Product NDC: 49288-0217
Proprietary Name: Gliocladium
Non Proprietary Name: Gliocladium
Active Ingredient(s): .05    g/mL & nbsp;   Gliocladium
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Gliocladium

Product NDC: 49288-0217
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19740323

Package Information of Gliocladium

Package NDC: 49288-0217-4
Package Description: 30 mL in 1 VIAL, MULTI-DOSE (49288-0217-4)

NDC Information of Gliocladium

NDC Code 49288-0217-4
Proprietary Name Gliocladium
Package Description 30 mL in 1 VIAL, MULTI-DOSE (49288-0217-4)
Product NDC 49288-0217
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Gliocladium
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19740323
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name MYROTHECIUM VERRUCARIA
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Gliocladium


General Information